Correction: Chidamide combined with doxorubicin induced p53-driven cell cycle arrest and cell apoptosis reverse multidrug resistance of breast cancer
Lixia Cao, Shaorong Zhao, Qianxi Yang, Zhendong Shi, Jingjing Liu, Teng Pan, Dongdong Zhou, Jin Zhang

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer-related Molecular Pathways · Chemotherapy-induced cardiotoxicity and mitigation · Advanced Breast Cancer Therapies
There was a mistake in “Figure 1 and Figure 2” as published. In “Figure 1E”, the Western blot image for GAPDH was incorrectly uploaded. In “Figure 2B, C”, the mistake was caused by an unintentional assembly mistake. In “Figure 2B”, an inadvertent image duplication occurred between the CON and DOX groups in the CALDOX cell line. In “Figure 2C”, it has come to our attention that the data presented were inadvertently taken from a different experimental replicate. The corrected “Figure 1 and Figure 2” appears below.
The original version of this article has been updated.
